MGI Pharma, Inc.

Baltimore, MD 21224

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $322K
First Award Date 10/03/05
Most Recent Award Date 10/26/05

Key Personnel

Last Name Name Awards Contact
Hamilton Gregory S Hamilton 1
Tsukamoto Takashi Tsukamoto 1

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-27
Budget: 10/26/05 - 03/31/07

DESCRIPTION (provided by applicant): The ultimate goal of this work is to commercialize a neuroimmunophilin ligand for cognition enhancement in patients with chronic neurodenerative disease. In preliminary studies in aged rats and primates, neuroimmunophilin ligands have been shown to enhance spatial learning and delayed matching-to-sample perfo...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 10/03/05 - 05/31/07

DESCRIPTION (provided by applicant): The goal of the proposed research is to determine the therapeutic utility of glutaminase inhibitors for the treatment of neurological disorders associated with glutamate excitotoxicity. We will undertake this research using potent and selective small molecule-based inhibitors of glutaminase. Our newly devel...